Poorly absorbed antibiotics for the treatment of traveler's diarrhea

David N. Taylor

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


This article describes the use of poorly absorbed antibiotics for the treatment of traveler's diarrhea. Poorly absorbed oral antibiotics can deliver high concentrations of drug to the site of enteric infection with minimal risk of systemic adverse effects, toxicity, and drug interactions. Compared with systemically absorbed oral antibiotics, poorly absorbed oral antibiotics may be less associated with the pressure that leads to the development of bacterial resistance, because they do not affect bacteria outside the gastrointestinal tract. In clinical studies, poorly absorbed oral antibiotics, including aztreonam, bicozamycin, and rifaximin, were more effective than and as well tolerated as placebo; in particular, rifaximin was as effective as oral ciprofloxacin in reducing the duration of illness in traveler's diarrhea. More research is warranted to delineate the effects of poorly absorbed antibiotics in invasive infection and to assess the potential for the development of bacterial resistance.

Original languageEnglish (US)
Pages (from-to)S564-S570
JournalClinical Infectious Diseases
Issue numberSUPPL. 11
StatePublished - Dec 1 2005
Externally publishedYes

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Poorly absorbed antibiotics for the treatment of traveler's diarrhea'. Together they form a unique fingerprint.

Cite this